HLBBetaKRX Filings & Disclosures 2026
Latest HLB (028300) DART disclosures in 2026 — including the most recent annual report filed on March 23, 2026. SignalX aggregates every new annual, half-year, quarterly, and material-event filing for HLB (028300) (KRX code 028300) from DART (Korea Financial Supervisory Service), with AI-powered English summaries of business overview, risk factors, and management discussion.
Latest 2026 DART Filing Dates
AI Annual Report AnalysisLatest Annual (2025-12-31)
Management Discussion & Analysis
- • Revenue KRW 84,173M (+23.6% YoY); Operating loss KRW -104,217M (-12.1% YoY); Net loss KRW -235,415M (+117.9% YoY)
- • Shipbuilding segment via subsidiary HLB Ocean Tech sales growth and new Original Archive sales drove revenue increase
Business Overview
- • KRW 84.17B total revenue in FY2025, with healthcare/bio at 23.4%, composite materials 59.7%, media commerce 16.2%
- • FDA NDA submitted May 2023 for Rivoceranib + Camrelizumab as first-line liver cancer, with ongoing FDA re-review and expected approval efforts in 2025
Risk Factors
- • KRW 79.6B notional cash flow from HLB Inc. 42nd bond with warrants maturing 2030-11-13 (units: KRW thousand in source table)
- • KRW 0.55B derivative asset from HLB Pep 3rd convertible bond with put option maturing 2028-04-08
Annual Reports ArchiveAnnual
AI-powered English analysis of HLB annual reports filed with DART.
Financial SummaryDART
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Balance Sheet | |||||
| Total Assets | KRW 743.7B | KRW 967.3B | KRW 751.7B | KRW 887.4B | KRW 930.2B |
| Equity | KRW 436.0B | KRW 637.9B | KRW 523.9B | KRW 576.6B | KRW 418.5B |
| Debt Ratio | 53.1% | 42.1% | 32.3% | 40.8% | 104.1% |
| Cash Flow | |||||
| Operating CF | -KRW 54.8B | -KRW 61.8B | -KRW 111.6B | -KRW 114.3B | -KRW 92.6B |
| CapEx | KRW 2.2B | KRW 11.7B | KRW 5.9B | KRW 20.0B | KRW 16.9B |
Source: KIFRS consolidated financial statements from HLB (KRX:028300) annual reports on DART. All figures in KRW.
Latest 2026 DART Filings
| Form | Filing Date | Period | Analysis | DART |
|---|---|---|---|---|
Annual Report | Mar 23, 2026 | Dec 31, 2025 | Analysis |
Frequently Asked Questions
What are the latest HLB DART filings in 2026?
HLB (KRX code 028300) has filed an annual report on March 23, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.
When did HLB file its most recent annual report?
HLB filed its most recent annual report on March 23, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.
What is HLB's KRX stock code?
HLB's KRX stock code is 028300. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 028300 to look up all HLB disclosures on DART, or browse them here on SignalX with AI-powered English analysis.
How often does HLB file with DART?
Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.
What is the difference between annual, half-year, and quarterly reports in Korea?
An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for HLB.
Where can I find HLB financial data and KIFRS metrics?
SignalX extracts KIFRS consolidated financial data from HLB annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.
Source: DART (Korea Financial Supervisory Service) · AI summaries generated from the original Korean filing (English output) · Beta: coverage is expanding